Skip to main content

Advertisement

Open Peer Review Reports for: Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
13 Sep 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
13 Sep 2013 Author responded Author comments - Yoshiya Horimoto
Resubmission - Version 3
13 Sep 2013 Submitted Manuscript version 3
16 Sep 2013 Author responded Author comments - Yoshiya Horimoto
Resubmission - Version 4
16 Sep 2013 Submitted Manuscript version 4
26 Dec 2013 Reviewed Reviewer Report - Peter Fasching
8 Jan 2014 Reviewed Reviewer Report - Carsten Denkert
4 Apr 2014 Author responded Author comments - Yoshiya Horimoto
Resubmission - Version 5
4 Apr 2014 Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
9 May 2014 Reviewed Reviewer Report - Peter Fasching
21 May 2014 Reviewed Reviewer Report - Carsten Denkert
8 Jun 2014 Author responded Author comments - Yoshiya Horimoto
Resubmission - Version 8
8 Jun 2014 Submitted Manuscript version 8
2 Jul 2014 Reviewed Reviewer Report - Peter Fasching
Resubmission - Version 9
Submitted Manuscript version 9
Publishing
23 Jul 2014 Editorially accepted
30 Jul 2014 Article published 10.1186/1471-2407-14-550

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement